SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:kth-321404"
 

Search: onr:"swepub:oai:DiVA.org:kth-321404" > Omics and Multi-Omi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Gurke, RobertFraunhofer Inst Translat Med & Pharmacol ITMP, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany. (author)

Omics and Multi-Omics Analysis for the Early Identification and Improved Outcome of Patients with Psoriatic Arthritis

  • Article/chapterEnglish2022

Publisher, publication year, extent ...

  • 2022-09-24
  • MDPI AG,2022
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:kth-321404
  • https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-321404URI
  • https://doi.org/10.3390/biomedicines10102387DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:for swepub-publicationtype

Notes

  • QC 20221115
  • The definitive diagnosis and early treatment of many immune-mediated inflammatory diseases (IMIDs) is hindered by variable and overlapping clinical manifestations. Psoriatic arthritis (PsA), which develops in similar to 30% of people with psoriasis, is a key example. This mixed-pattern IMID is apparent in entheseal and synovial musculoskeletal structures, but a definitive diagnosis often can only be made by clinical experts or when an extensive progressive disease state is apparent. As with other IMIDs, the detection of multimodal molecular biomarkers offers some hope for the early diagnosis of PsA and the initiation of effective management and treatment strategies. However, specific biomarkers are not yet available for PsA. The assessment of new markers by genomic and epigenomic profiling, or the analysis of blood and synovial fluid/tissue samples using proteomics, metabolomics and lipidomics, provides hope that complex molecular biomarker profiles could be developed to diagnose PsA. Importantly, the integration of these markers with high-throughput histology, imaging and standardized clinical assessment data provides an important opportunity to develop molecular profiles that could improve the diagnosis of PsA, predict its occurrence in cohorts of individuals with psoriasis, differentiate PsA from other IMIDs, and improve therapeutic responses. In this review, we consider the technologies that are currently deployed in the EU IMI2 project HIPPOCRATES to define biomarker profiles specific for PsA and discuss the advantages of combining multi-omics data to improve the outcome of PsA patients.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Bendes, AnnikaKTH,Affinitets-proteomik,Science for Life Laboratory, SciLifeLab(Swepub:kth)u1ea2ghd (author)
  • Bowes, JohnManchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester M13 9WU, Lancs, England.;Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Ctr Musculoskeletal Res,Ctr Genet & Genom Versus, Manchester M13 9PT, Lancs, England. (author)
  • Koehm, MichaelaFraunhofer Inst Translat Med & Pharmacol ITMP, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Univ Hosp Frankfurt, Div Rheumatol, Theodor Stern Kai 7, D-60596 Frankfurt, Germany. (author)
  • Twyman, Richard M.TRM Ltd, POB 493, Scarborough YO11 9FJ, England. (author)
  • Barton, AnneManchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester M13 9WU, Lancs, England.;Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Ctr Musculoskeletal Res,Ctr Genet & Genom Versus, Manchester M13 9PT, Lancs, England. (author)
  • Elewaut, DirkUniv Ghent, VIB UGent Ctr Inflammat Res, B-9052 Ghent, Belgium. (author)
  • Goodyear, CarlUniv Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland. (author)
  • Hahnefeld, LisaFraunhofer Inst Translat Med & Pharmacol ITMP, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany. (author)
  • Hillenbrand, RainerNovartis Pharma AG, CH-4056 Basel, Switzerland. (author)
  • Hunter, EwanOxford BioDynam Ltd, Oxford OX4 2JZ, England. (author)
  • Ibberson, MarkSIB Swiss Inst Bioinformat, Vital IT Grp, CH-1015 Lausanne, Switzerland. (author)
  • Ioannidis, VassiliosSIB Swiss Inst Bioinformat, Vital IT Grp, CH-1015 Lausanne, Switzerland. (author)
  • Kugler, SabineFraunhofer Cluster Excellence Immune Mediated Dis, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer IAIS, Inst Intelligent Anal & Informat Syst, Schloss Birlinghoven 1, D-53757 St Augustin, Germany. (author)
  • Lories, Rik J.Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, POB 813 O&N,Herestr 49, B-3000 Leuven, Belgium. (author)
  • Resch, EduardFraunhofer Inst Translat Med & Pharmacol ITMP, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Theodor Stern Kai 7, D-60596 Frankfurt, Germany. (author)
  • Rueping, StefanFraunhofer Cluster Excellence Immune Mediated Dis, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer IAIS, Inst Intelligent Anal & Informat Syst, Schloss Birlinghoven 1, D-53757 St Augustin, Germany. (author)
  • Scholich, KlausFraunhofer Inst Translat Med & Pharmacol ITMP, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany. (author)
  • Schwenk, Jochen M.KTH,Science for Life Laboratory, SciLifeLab,Affinitets-proteomik(Swepub:kth)u1h7wtme (author)
  • Waddington, James C.Univ Coll Dublin, UCD Conway Inst, Atturos Ltd, Dublin D04 V1W8, Ireland. (author)
  • Whitfield, PhilUniv Glasgow, Coll Med Vet & Life Sci, Glasgow Polyom, Garscube Campus, Glasgow G61 1QH, Lanark, Scotland. (author)
  • Geisslinger, GerdFraunhofer Inst Translat Med & Pharmacol ITMP, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany. (author)
  • FitzGerald, OliverUniv Coll Dublin, Sch Med, UCD Conway Inst, Dublin D04 V1W8, Ireland. (author)
  • Behrens, FrankFraunhofer Inst Translat Med & Pharmacol ITMP, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Univ Hosp Frankfurt, Div Rheumatol, Theodor Stern Kai 7, D-60596 Frankfurt, Germany. (author)
  • Pennington, Stephen R.Univ Coll Dublin, UCD Conway Inst, Atturos Ltd, Dublin D04 V1W8, Ireland.;Univ Coll Dublin, Sch Med, UCD Conway Inst, Dublin D04 V1W8, Ireland. (author)
  • Fraunhofer Inst Translat Med & Pharmacol ITMP, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.;Fraunhofer Cluster Excellence Immune Mediated Dis, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.Affinitets-proteomik (creator_code:org_t)

Related titles

  • In:Biomedicines: MDPI AG10:102227-9059

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view